115
Views
19
CrossRef citations to date
0
Altmetric
Case Report

Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines

&
Pages 281-284 | Published online: 09 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jürgen Frevert, Ki Young Ahn, Mee Young Park & Owen Sunga. (2018) Comparison of botulinum neurotoxin type A formulations in Asia. Clinical, Cosmetic and Investigational Dermatology 11, pages 327-331.
Read now
Sebastian Torres, Mark Hamilton, Elena Sanches, Polina Starovatova, Elena Gubanova & Tatiana Reshetnikova. (2014) Neutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine: five case reports. Clinical, Cosmetic and Investigational Dermatology 7, pages 11-17.
Read now
Welf Prager. (2013) Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines. Clinical Pharmacology: Advances and Applications 5, pages 39-52.
Read now
Thomas Rappl, Daryousch Parvizi, Herwig Friedl, Maria Wiedner, Simone May, Bettina Kranzelbinder, Paul Wurzer & Bengt Hellbom. (2013) Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study. Clinical, Cosmetic and Investigational Dermatology 6, pages 211-219.
Read now

Articles from other publishers (15)

Je-Young Park, Niamh Corduff, Jürgen Frevert, Rungsima Wanitphakdeedecha & Yates Y.Y. Chao. (2022) Immunogenicity Associated with Aesthetic Botulinumtoxin A: A Survey of Asia-Pacific Physicians’ Experiences and Recommendations. Plastic and Reconstructive Surgery - Global Open 10:4, pages e4217.
Crossref
Napamon Supornpun, Paisal Rummaneethorn, Thamthiwat Nararatwanchai, Tawee Saiwichai & Sirinthip Chaichalotornkul. (2022) Incobotulinum toxin A with a one-year long-lasting effect for trapezius contouring and superior efficacy for the treatment of trapezius myalgia. Journal of Cutaneous and Aesthetic Surgery 15:2, pages 168.
Crossref
Wilson W. S. Ho, Philipp Albrecht, Pacifico E. Calderon, Niamh Corduff, David Loh, Michael U. Martin, Je-Young Park, Lis S. Suseno, Fang-Wen Tseng, Vasanop Vachiramon, Rungsima Wanitphakdeedecha, Chong-Hyun Won, Jonathan N. T. Yu & Mary Dingley. (2022) Emerging Trends in Botulinum Neurotoxin A Resistance: An International Multidisciplinary Review and Consensus. Plastic and Reconstructive Surgery - Global Open 10:6, pages e4407.
Crossref
Souphiyeh Samizadeh & Rajiv Grover. 2022. Non-Surgical Rejuvenation of Asian Faces. Non-Surgical Rejuvenation of Asian Faces 193 211 .
Yuttana Srinoulprasert & Rungsima Wanitphakdeedecha. (2020) Antibody‐induced botulinum toxin treatment failure: A review and novel management approach. Journal of Cosmetic Dermatology 19:10, pages 2491-2496.
Crossref
Je-Young Park, Owen Sunga, Rungsima Wanitphakdeedecha & Jürgen Frevert. (2020) Neurotoxin Impurities: A Review of Threats to Efficacy. Plastic and Reconstructive Surgery - Global Open 8:1, pages e2627.
Crossref
Debraj Shome, Rinky Kapoor & Stuti Khare. (2019) Two different types of botulinum toxins: Is there a difference in efficacy and longevity?. Journal of Cosmetic Dermatology 18:6, pages 1635-1641.
Crossref
Neal D. Varughese & David J. Goldberg. 2017. Botulinum Toxins. Botulinum Toxins 133 145 .
Cerrene N. Giordano, Seth L. Matarasso & David M. Ozog. (2017) Injectable and topical neurotoxins in dermatology. Journal of the American Academy of Dermatology 76:6, pages 1027-1042.
Crossref
Jürgen Frevert. (2015) Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products. Drugs in R&D 15:1, pages 1-9.
Crossref
Doris Hexsel & Taciana Dal’Forno Dini. (2014) Advanced Botulinum Toxin Injections for Dynamic Rhytides: Treating the Upper Face, Lower Face, and Beyond. Current Dermatology Reports 3:2, pages 103-112.
Crossref
Joel Schlessinger, Jeffrey S. Dover, John Joseph, Gary Monheit, Diane B. Nelson, Craig D. Albright, Robert A. Axford-Gatley & Joel L. Cohen. (2014) Long-Term Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines: Results From a 36-Month, Multicenter, Open-Label Extension Study. Dermatologic Surgery 40:2, pages 176-183.
Crossref
Sarah Khan, Emerald Lin & Jonathan S. Kirschner. 2014. Atlas of Ultrasound Guided Musculoskeletal Injections. Atlas of Ultrasound Guided Musculoskeletal Injections 101 121 .
Matthias Imhof, Maurizio Podda & Boris Sommer. (2013) S1 guideline aesthetic botulinum toxin therapy. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11:10, pages e1-e13.
Crossref
A. Pickett. (2013) Moderne Ansätze für Botulinumtoxin in der ästhetischen MedizinModern approaches to botulinum toxin applications in aesthetics. Journal für Ästhetische Chirurgie 6:3, pages 166-172.
Crossref